Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Fixes Retail...

NPPA Fixes Retail Price Of 25 Formulations, Details

Susmita RoyWritten by Susmita Roy Published On 2023-03-28T18:00:13+05:30  |  Updated On 25 Oct 2023 2:59 PM IST
NPPA Fixes Retail Price Of 25 Formulations, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of India has fixed retail prices for 25 formulations including those used to treat high blood pressure, type 2 diabetes, cholesterol, bacterial infections, asthma.

This came in line with the decision of the 110th Authority meeting dated 23.03.2023.

These include Skymap Pharmaceuticals/German Remedies Pharmaceutical's Glimepiride tablets, Akums /Sun Pharmaceutical's Bilastine and Montelukast Orodispersible Tablets, Synokem Pharmaceuticals / Alembic Pharmaceutical's Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets, Akums/ Emcure Pharmaceutical's Levocetirizine, Montelukast & (SR) Ambroxol Hydrochloride Tablets, Lupin's Bisoprolol Fumarate & Amlodipine Tablets, Akums Drugs & Pharmaceuticals /Glenmark Pharmaceutical's Cilnidipine & Telmisartan Tablets and others.

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;


Sl.

No.

Name of the

Formulation / Brand Name

Strength

Unit

Manufacturer &

Marketing Company

Retail

Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Itraconazole Capsules (Supra- Bioavailable

Formulation)

Each Hard Gelatin Capsule contains:

Itraconazole BP 130mg

1

Capsule

M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Abbott Healthcare Pvt.

Ltd.

20.72

2

Telmisartan & Chlorthalidone Tablets

Each uncoated bilayered tablet contains: Telmisartan IP 40mg

Chlorthalidone IP 6.25mg

1 Tablet

M/s Innova Captab Limied / M/s Indoco

Remedies Limited

8.04

3

Camylofin Dihydrochlorid e and Paracetamol

Tablets

Each film coated tablet contains:

Camylofin Dihydrochloride 50mg

Paracetamol IP 325mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Abbott Healthcare

Pvt. Ltd.

5.53

4

Glimepiride tablets IP

Each uncoated tablet contains:

Glimepiride IP 4mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals

Pvt. Ltd.

11.57

5

Glimepiride tablets IP

Each uncoated tablet contains:

Glimepiride IP 3mg

1 Tablet

M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s German Remedies

Pharmaceuticals Pvt. Ltd.

9.77

6

Gliclazide

Each uncoated bilayered

1 Tablet

M/s Swiss

6.57


Sl.

No.

Name of the Formulation /

Brand Name

Strength

Unit

Manufacturer & Marketing

Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

(MR) and Metformin Hydrochloride (ER) Tablets

tablet contains:

Gliclazide IP 30mg (in MR form)

Metformin Hydrochloride IP 500mg (as Extended

Release)

Garniers Genexiaa Sciences Pvt. Ltd.

/ M/s Servier India Pvt. Ltd.

7

Bilastine and Montelukast Orodispersible Tablets

Each uncoated Orodispersible tablet contains:

Montelukast Sodium IP Eq. to Montelukast 10mg

Bilastine 20mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Sun Pharmaceuticals

Industries Limited

13.21

8

Chlorpheniram ine Maleate and Phenylephrine Hydrochloride

Syrup

Each 5ml contains: Chlorpheniramine Maleate IP 2mg

Phenylephrine Hydrochloride IP 5mg

1 ml

M/s Stedman Pharmaceuticals Pvt. Ltd.

1.16

9

Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Metformin Hydrochloride IP (Extended Release)

1000mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Alembic Pharmaceuticals Ltd.

7.31

10

Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Metformin Hydrochloride IP (Extended Release)

1000mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Alembic Pharmaceuticals Ltd.

10.53

11

Dapagliflozin & Metformin Hydrochloride (Extended Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Metformin Hydrochloride IP

(Extended Release) 500mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Alembic Pharmaceuticals Ltd.

9.10

12

Dapagliflozin and Metformin Hydrochloride (as Extended Release) Tablets

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Metformin Hydrochloride IP

500mg (as Extended Release)

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Prime Labs Pvt. Ltd.

9.10

13

Dapagliflozin and Metformin Hydrochloride (as Extended Release)

Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg

1 Tablet

M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Prime Labs Pvt. Ltd.

10.53


Sl.

No.

Name of the Formulation /

Brand Name

Strength

Unit

Manufacturer & Marketing

Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Tablets

Metformin Hydrochloride IP 1000mg (as Extended

Release)

14

Levocetirizine, Montelukast & (SR) Ambroxol Hydrochloride Tablets

Each uncoated bilayered tablet contains: Levocetirizine Dihydrochloride IP 5mg Montelukast Sodium IP eq. to Anhydrous Montelukast 10mg

Ambroxol Hydrochloride IP 75mg (As Sustained Release)

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Emcure Pharmaceuticals Ltd.

15.39

15

Omeprazole & Domperidone Capsules IP

Each hard gelatin capsule contains:

Omeprazole IP 20mg (as gastro-resistant pellets) Domperidone IP 10mg (as

pellets)

1

Capsule

M/s Innova Captab Ltd. / M/s Torrent Pharmaceuticals Limited

5.90

16

Combi pack of Clarithromycin Tablets IP, Esomeprazole Tablets IP & Amoxicillin Tablets USP

Each Strip contains:

  1. Clarithromycin Tablets IP 2 Tablets

Each film coated tablet contains:

Clarithromycin IP 500mg

  1. Esomeprazole Tablets IP 2 Tablets

Each Enteric coated tablet contains:

Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg

  1. Amoxicillin Tablets USP 2 Tablets

Each Film coated tablet contains:

Amoxycillin Trihydrate IP eq. to Amoxycillin 750mg

Combi Pack of 6 Tablets

M/s Malik Lifesciences Pvt. Ltd. / M/s Zuventus Healthcare Limited

152.17

17

Bisoprolol Fumarate & Amlodipine Besylate

tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq.

to Amlodipine 5mg

1 Tablet

M/s Tha Madras Pharmaceuticals / M/s Cipla Ltd.

8.34

18

Bisoprolol Fumarate & Amlodipine Besylate tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 2.5mg

Amlodipine Besylate IP Eq. to Amlodipine 5mg

1 Tablet

M/s Tha Madras Pharmaceuticals / M/s Cipla Ltd.

6.19

19

Erythropoietin Injection BP 6000 IU/ml

Each pre-filled Syringe contains:

Erythropoietin Concentrated Solution IP 6000IU

Albumin Human IP 2.5mg

1 Vial

M/s Gennova Biopharmaceutica ls Ltd. / M/s Wockhardt

Limited

1449.7

4


Sl.

No.

Name of the Formulation /

Brand Name

Strength

Unit

Manufacturer & Marketing

Company

Retail Price

(Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

Sodium Chloride IP 5.8mg Sodium Citrate IP 5.8mg Citric Acid monohydrate IP 5.8mg

Water for Injections IP (q.s.

to 1ml)

20

Glycopyrroniu m Ph. Eur, Formoterol Fumarate IP and Budesonide Inhalation

powder

Each Capsule contains: Glycopyrronium Bromide Ph. Eur eq. to Glycopyrronium 25mcg, Formoterol Fumarate (As Formoterol Fumarate Dihydrate IP) 12mcg

Budesonide IP 400mcg

1

Capsule

M/s Lupin Limited

12.19

21

Bisoprolol Fumarate & Amlodipine Tablets

Each film coated tablet contains:

Bisoprolol Fumarate IP 5mg

Amlodipine Besylate IP Eq. to Amlodipine 5mg

1 Tablet

M/s J. K.

Printpack /M/s Zydus Healthcare Limited

8.34

22

Cilnidipine & Telmisartan Tablets

Each film coated tablet contains:

Cilnidipine IP 20mg Telmisartan IP 40mg

1 Tablet

M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Glenmark Pharmaceuticals

Limited

12.83

23

Ceftazidime and Avibactam powder for concentrate for solution for

infusion

Each vial contains: Ceftazidime (as ceftazidime Pentahydrate) IP 2gram Avibactam Sodium eq. to Avibactam 0.5gm

1 ml

M/s BDR Pharmaceuticals International Pvt. Ltd. / M/s Wockhardt Limited

3773.3

1

24

Cilnidipine, Telmisartan & Chlorthalidone Tablets

Each film coated tablet contains:

Cilnidipine IP 10mg Telmisartan IP 40mg Chlorthalidone IP 6.25mg

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Aristo Pharmaceuticals

Pvt. Ltd.

13.17

25

ORS with Zinc powder 4.38g

Each sachet of 4.38g contains:

Zinc Sulfate Monohydrate IP 0.011g

Sodium Citrate IP 0.58g Potassium Chloride IP 0.30g

Sodium Chloride IP 0.52g

Dextrose Anhydrous IP 2.70g

1 Sachet

M/s FDC Limited

6.12

The notification further added,

(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column

(2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

Also Read:NPPA fixes retail price of FDC to treat Nutritional deficiencies marketed by Abbott

npparetail pricesun pharmalupinglimepirideGlenmarkmontelukast
Susmita Roy
Susmita Roy

    Mpharm (Pharmacology)

    Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok